Genotropin Therapy Slows Vision Decline in American Males with Retinitis Pigmentosa: 3-Year Study
Reading Time: 3 minutes Introduction Retinitis Pigmentosa (RP) is a group of genetic disorders that cause progressive vision loss, primarily affecting the photoreceptor cells in the retina. This condition poses a significant challenge to affected individuals, particularly American males, who may experience a decline in their quality of life due to the progressive nature of the disease. Recent studies have explored the potential of Genotropin, a recombinant human growth hormone, in managing the symptoms of RP. This article presents a comprehensive evaluation of the impact of Genotropin therapy on vision in American males with RP over a three-year period. Study Design and Methodology The...


